Gyre Therapeutics GYRE
NASDAQ GYRE
$7.19 +0.19 (+2.72%)
As of: Oct 2, 2026 · 2:48 PM EDT

Gyre Therapeutics (GYRE) Other Non-Current Assets (2011 - 2026)

Updated

Gyre Therapeutics (GYRE) posted Other Non-Current Assets of $7.34 million for Q2 2026, up 37.6% from $5.34 million a year earlier and up 48.6% from the prior quarter.

Analysis

Gyre Therapeutics (GYRE) Other Non-Current Assets (2011 - 2026) Analysis & Trends

At the end of FY2025, Gyre Therapeutics' Other Non-Current Assets came in at $7.62 million, up 151.6% from FY2024.

  • Annual Other Non-Current Assets shows a five-year compound annual growth rate of 70.6% (FY2020 to FY2025).
  • In prior years, Gyre Therapeutics' Other Non-Current Assets was $3.03 million in FY2024 (+204.5%), $995,000 in FY2023 (-70.7%), $3.39 million in FY2022 (+619.1%) and $472,000 in FY2021 (-10.6%).
  • Quarterly Other Non-Current Assets has run from a low of $168,000 in Q2 2022 to a high of $7.62 million in Q4 2025 over five years.
  • On a year-over-year basis, Other Non-Current Assets increased in six of the last seven quarters, with growth averaging 197.9%.
  • The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q2 2024, with growth of 660.7%; the weakest was Q2 2022, with a decline of 85.6%.
  • According to Business Quant data, Other Non-Current Assets for the three prior quarters was $4.94 million (Q1 2026), $7.62 million (Q4 2025) and $5.32 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Gyre Therapeutics 777.23 Mn 579.94 Mn 26.90 Mn 7.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.34 Mn
Mar 31, 2026 4.94 Mn
Dec 31, 2025 7.62 Mn
Sep 30, 2025 5.32 Mn
Jun 30, 2025 5.34 Mn
Mar 31, 2025 5.56 Mn
Dec 31, 2024 3.03 Mn
Sep 30, 2024 2.77 Mn
Jun 30, 2024 1.28 Mn
Mar 31, 2024 802,000.00
Dec 31, 2023 995,000.00
Sep 30, 2023 168,000.00
Jun 30, 2023 168,000.00
Mar 31, 2023 168,000.00
Dec 31, 2022 3.39 Mn
Sep 30, 2022 168,000.00
Jun 30, 2022 168,000.00
Mar 31, 2022 472,000.00
Dec 31, 2021 472,000.00
Sep 30, 2021 869,000.00
API Access

Gyre Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=GYRE&period=max&api_key=YOUR_API_KEY